EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 38 / No 3 (Mars 2022) Med Sci (Paris), 38 3 (2022) 321-324 References
Issue
Med Sci (Paris)
Volume 38, Number 3, Mars 2022
Nos jeunes pousses ont du talent !
Page(s) 321 - 324
Section Partenariat médecine/sciences - Écoles doctorales - Masters
DOI https://doi.org/10.1051/medsci/2022020
Published online 25 March 2022
  1. Klepper A, Branch AD. Macrophages and the Viral Dissemination Super Highway. EC Microbiol 2015 ; 2 : 328–336. [PubMed] [Google Scholar]
  2. Groslambert M, Py BF. NLRP3, un inflammasome sous contrôle. Med Sci (Paris) 2018 ; 34 : 47–53. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Gaidt MM, Hornung V. The NLRP3 Inflammasome Renders Cell Death Pro-inflammatory. J Mol Biol 2018 ; 430 : 133–141. [CrossRef] [PubMed] [Google Scholar]
  4. Hendrickx R, Stichling N, Koelen J, et al. Innate Immunity to Adenovirus. Human Gene Therapy 2014 ; 25 : 265–284. [CrossRef] [PubMed] [Google Scholar]
  5. Labzin LI, Bottermann M, Rodriguez-Silvestre P, et al. Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection. EMBO J 2019 ; 38 : e101365. [CrossRef] [PubMed] [Google Scholar]
  6. Wold W, Toth K. Adenovirus Vectors for Gene Therapy. Vaccination and Cancer Gene Therapy. CGT 2014 ; 13 : 421–433. [Google Scholar]
  7. Bressy C, Benihoud K. Association of oncolytic adenoviruses with chemotherapies: An overview and future directions. Biochem Pharmacol 2014 ; 90 : 97–106. [CrossRef] [PubMed] [Google Scholar]
  8. Zaiss AK, Vilaysane A, Cotter MJ, et al. Antiviral Antibodies Target Adenovirus to Phagolysosomes and Amplify the Innate Immune Response. J Immunol 2009 ; 182 : 7058–7068. [CrossRef] [PubMed] [Google Scholar]
  9. Barlan AU, Griffin TM, Mcguire KA, Wiethoff CM. Adenovirus Membrane Penetration Activates the NLRP3 Inflammasome. J Virol 2011 ; 85 : 146–155. [CrossRef] [PubMed] [Google Scholar]
  10. Foss S, Bottermann M, Jonsson A, et al. TRIM21-From Intracellular Immunity to Therapy. Front Immunol 2019 ; 10 : 2049. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.